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ABSTRACT
Metnase is a human protein with methylase (SET)
and nuclease domains that is widely expressed,
especially in proliferating tissues. Metnase
promotes non-homologous end-joining (NHEJ),
and knockdown causes mild hypersensitivity to
ionizing radiation. Metnase also promotes plasmid
and viral DNA integration, and topoisomerase IIa
(TopoIIa)-dependent chromosome decatenation.
NHEJ factors have been implicated in the replication
stress response, and TopoIIa has been proposed to
relax positive supercoils in front of replication forks.
Here we show that Metnase promotes cell prolifer-
ation, but it does not alter cell cycle distributions, or
replication fork progression. However, Metnase
knockdown sensitizes cells to replication stress
and confers a marked defect in restart of stalled
replication forks. Metnase promotes resolution of
phosphorylated histone H2AX, a marker of DNA
double-strand breaks at collapsed forks, and it
co-immunoprecipitates with PCNA and RAD9, a
member of the PCNA-like RAD9–HUS1–RAD1
intra-S checkpoint complex. Metnase also
promotes TopoIIa-mediated relaxation of positively
supercoiled DNA. Metnase is not required for RAD51
focus formation after replication stress, but
Metnase knockdown cells show increased RAD51
foci in the presence or absence of replication
stress. These results establish Metnase as a key
factor that promotes restart of stalled replication
forks, and implicate Metnase in the repair of
collapsed forks.
INTRODUCTION
Cellular systems that maintain genome stability are critical
for cancer suppression. The failure to accurately repair
DNA damage, including single-strand damage and
double-strand breaks, is strongly linked to cancer initi-
ation and progression. DNA damage is caused by intrinsic
factors associated with cellular metabolism, such as
reactive oxygen species and hydrogen peroxide, and ex-
trinsic factors, such as ionizing radiation, UV radiation
and chemotherapeutic agents including reactive chemicals,
topoisomerase poisons and hydroxyurea (HU) which
depletes nucleotide pools (1,2). Cells are particularly vul-
nerable to DNA damage during DNA replication because
many DNA lesions cause replication forks to stall.
Cellular responses to replication stress are extremely
important in cancer therapy, as a number of
chemotherapeutic drugs target DNA metabolism and
cause replication stress, including topoisomerase poisons
and HU. Cells respond to stalled forks in several ways.
Single-stranded DNA (ssDNA) bound by RPA accumu-
lates at stalled forks and is a major signal for downstream
events including fork repair and checkpoint activation.
The replisome at stalled forks is stabilized by proteins
that function in DNA repair and the DNA damage
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ATM, BLM and INO80 (3–6); the action of these
proteins may preserve the fork structure while the
damage is repaired, allowing replication to resume.
Alternatively, error-prone translesion synthesis (TLS)
polymerases may be recruited to monoubiquitinated
proliferating cell nuclear antigen (PCNA), allowing
lesion bypass in a damage tolerance pathway (7,8). Type
I and II topoisomerases play key roles in normal DNA
replication. Topoisomerase I (type I) is thought to play a
major role in relaxing positive supercoils produced in
front of replication forks during duplex DNA unwinding
by the replicative helicase. Topoisomerase IIa (TopoIIa),
a type II enzyme, has roles in chromosome condensation
and decatenation, is also present in the replisome, and is
proposed to relax positive supercoils ahead of replication
forks (9–11). Although it is known that topoisomerase
poisons cause replication stress, speciﬁc roles for topo-
isomerases in response to replication stress have not
been deﬁned.
If stalled forks are not restarted in a timely manner,
they may be converted to unusual DNA structures and
collapse creating a one-ended double-strand break or
‘double-strand end’ (DSE). Certain types of damage,
such as single-strand breaks, may cause direct fork
collapse to DSEs. As with double-strand breaks, the
checkpoint kinases ATM and ATR are recruited to
DSEs and activated, leading to histone H2AX phosphor-
ylation (g-H2AX) in the vicinity of DSEs (12). This chro-
matin modiﬁcation is important for fork repair and
checkpoint activation, and once collapsed forks are
repaired, g-H2AX is replaced by unmodiﬁed H2AX
(13–15). Homologous recombination (HR), involving
RAD51-mediated strand invasion, plays a major role
in restarting stalled and collapsed forks (5). NHEJ
factors also play a role in cell survival after replication
stress (16).
Replication stress activates the intra-S checkpoint (5).
ssDNA–RPA at stalled forks is bound by ATRIP leading
to activation of its obligate binding partner ATR. ATR
activation depends on RAD17 (plus Rfc2-5) loading of the
RAD9–HUS1–RAD1 complex (9-1-1; a scaﬀold and
processivity factor structurally related to PCNA)
through a RAD9–RPA interaction. RAD9 recruits
TopBP1, an essential factor for ATR activation. ATR
phosphorylates RAD17, which recruits Claspin to be
phosphorylated by ATR, and phosphorylated RAD17-
Claspin promotes ATR phosphorylation/activation of
Chk1 kinase which phosphorylates proteins that stabilize
the stalled fork and prevent late origin ﬁring.
Metnase is a human protein that interacts with DNA
ligase IV, TopoIIa, Pso4 and NBS1, and promotes NHEJ,
DNA integration and TopoIIa-dependent chromosome
decatenation (17–20). Metnase has SET (protein
methylase) and nuclease domains. It methylates histone
H3 at lysines 4 and 36, which are associated with ‘open’
chromatin and may increase accessibility of repair factors
to damaged DNA. Metnase knockdown confers mild sen-
sitivity to ionizing radiation (17). Because Metnase func-
tions in NHEJ and regulates TopoIIa activity, we
investigated whether it plays a role in replication or
replication fork restart after stress. We show here that
Metnase promotes cell proliferation, and cell survival
after replication stress caused by HU, the topoisomerase
I poison camptothecin (CPT), and UV-B. Metnase does
not inﬂuence replication fork progression, but it strongly
inﬂuences restart of stalled forks. Additionally,
it co-immunoprecipates with PCNA and RAD9. We
further show that Metnase promotes resolution of
HU-induced g-H2AX foci, and enhances TopoIIa-
dependent relaxation of positively supercoiled DNA.
These results establish Metnase as a key regulatory
factor in the human replication stress response.
MATERIALS AND METHODS
Cell lines, RNAi-suppression of Metnase and expression
of V5-tagged Metnase
Cell lines were cultured in D-MEM with 10% (v/v) fetal
bovine serum supplemented with 100 U/ml penicillin and
100mg/ml streptomycin, or 1 antimycotic/antibiotic
(Invitrogen, Carlsbad, CA). Metnase was overexpressed
in HEK-293 and HEK-293T cells as described (19).
V5-tagged Metnase expression was conﬁrmed by western
blot with a monoclonal antibody against the V5 tag
(Invitrogen). Metnase was down-regulated by transfecting
cells with a pRNA/U6-Metnase RNAi vector and select-
ing in growth medium with 150–200mg/ml hygromycin B
(Sigma-Aldrich, St. Louis, MO), or with an Metnase
shRNA vector (pRS-shMetnase). Control cells were trans-
fected with empty pRNA/U6 or pRS-shGFP vectors.
Metnase expression was measured by RT–PCR and by
western blots using antibodies to native Metnase as
described (17). As noted below, ‘stable’ knockdown of
Metnase causes growth defects, and cell lines typically
revert or cease to grow after 2 months. This necessitates
frequent reconstruction of Metnase knockdown cell lines
(designated shMet-11, 47, etc.). For each new construc-
tion, Metnase knockdown was conﬁrmed by western
blot and RT-PCR.
Cell proliferation and replication stress sensitivity assays
Cell proliferation was analyzed in triplicate in treated or
mock-treated populations incubated in fully supplemented
media at 37C, 5% CO2, and at indicated times cells were
harvested and counted with a Coulter counter. Cell sensi-
tivity to CPT and HU was determined by seeding 1000
cells per 10cm (diameter) dish in drug-free medium (to
determine plating eﬃciency, PE), and 100000 cells per
dish in medium with CPT or HU, incubating for indicated
times, then cells were rinsed with PBS, fresh growth
medium was added, and cells were incubated for 12–14
days before colonies were stained with 0.1% crystal
violet in methanol and counted. For UV sensitivity, cells
were seeded and incubated for 24h as above, rinsed with
PBS, exposed to UVB in a biological safety cabinet
equipped with a Phillips UVB ﬂuorescent bulb, then
fresh growth medium was added and cells were incubated
and colonies scored. UV doses were determined by using a
UVX dosimeter (UVP, Upland, CA). PE was calculated as
the number of colonies divided by the number of cells
5682 Nucleic Acids Research, 2010,Vol.38, No. 17plated without drug or UVB treatment. Percent survival
was calculated as the number of colonies formed with drug
or UVB treatment divided by the number of cells plated
times the PE.
Cell cycle distributions and cell death
Cell cycle distributions were measured by ﬁxing cells with
70% ethanol and staining with 0.2mg/ml propidium
iodide in a fresh solution containing 1% (v/v) Triton
X-100 and 2U of DNAse-free RNAse (all from
Sigma-Aldrich) for 15min at 37C or 30min at room tem-
perature. Samples were analyzed using a FACScan or a
FACScalibur ﬂow cytometer (Becton Dickinson, Franklin
Lakes, NJ). The percentages of cells in G1, S or G2/M
phases were calculated by dividing the number of cells in
each cell cycle stage by the total number of PI positive cells
after normalizing to controls that were not stained with PI
and converting values to percentages. Apoptosis and cell
death were analyzed by ﬂow-cytometric measurement of
annexin-V expression and propidium iodide incorporation
by using the Annexin V-FITC Apoptosis Detection Kit I
(BD Pharmingen, San Diego, CA). All ﬂow cytometry
data were analyzed with FlowJo software (Ashland, OR,
http://www.ﬂowjo.com/).
DNA replication by BrdU incorporation and DNA ﬁber
analysis
Log phase cells, or cells treated with 5mM HU for 3 or
18h were washed with PBS and released into fully supple-
mented D-MEM containing 10mM BrdU. Aliquots were
removed at indicated times, cells were ﬁxed,
permeabilized, and stained using the FITC BrdU Flow
Kit (BD Pharmingen), and analyzed by ﬂow cytometry
as above. DNA ﬁbers were analyzed as described (21).
Brieﬂy, cells were grown in 6-well tissue culture dishes,
20mM IdU was added to growth medium, mixed and
incubated for 10min at 37C. Media was removed and
cells were washed with PBS, followed by a 100mM thymi-
dine wash. Then, cells were either treated with HU or
mock treated, medium was replaced with fresh medium
containing 20mM CldU and cells were incubated for
20min at 37C. Cells were harvested, resuspended in
PBS, 2500 cells were transferred to a positively charged
microscope slide (Superfrost/Plus, Daigger, Vernon Hills,
IL), lysed with 6ml of0.5% SDS, 200mM Tris–HCl, pH
7.4, 50mM EDTA and incubated at room temperature for
5min. Slides were tilted to allow DNA to spread via
gravity, covered with aluminum foil, air-dried for 8min,
ﬁxed for 5min with 3:1 methanol:acetic acid (prepared
fresh), air dried for 8min, and stored in 70% ethanol at
4C overnight. Slides were deproteinized in 2.5N HCl at
37C for 1h, blocked with 5% BSA and labeled sequen-
tially for 1h each with mouse anti-BrdU antibody (BD
Biosciences, San Jose, CA), secondary goat anti-mouse
Alexa 568 (Invitrogen), rat anti-BrdU (Accurate
Chemical, Westbury, NY) and secondary donkey
anti-rat Alexa 488 (Invitrogen). Slides were mounted in
PermaFluor aqueous, self-sealing mounting medium
(Thermoscientiﬁc, Waltham, MA). DNA ﬁbers were
visualized using an LSM 510 confocal microscope
(Zeiss, Thornwood, NY) optimized for each Alexa dye.
Images were analyzed using Zeiss LSM Image Browser
software.
Analysis of c-H2AX and RAD51 foci
Cells were treated with 10mM HU for indicated times in
fully supplemented D-MEM, released into fully supple-
mented D-MEM for indicated times, harvested,
cytospun, ﬁxed, and processed for immunoﬂuorescence
microscopy with g-H2AX or RAD51 primary antibodies
and appropriate secondary antibodies as described previ-
ously (22,23). Images were obtained with a Zeiss 510
inverted microscope or a Radiance 2100 inverted
confocal microscope (BioRad, Hercules, CA) ﬁtted with
appropriate ﬁlter sets for DAPI and FITC/Alexa ﬂuors.
Images were optimized consistently with Photoshop or
ImageJ software (http://rsb.info.nih.gov/ij/).
Protein immunoprecipitation
Protein samples were pre-treated with 4 U of DNaseI,
incubated at 37C for 10min, immunoprecipitated using
0.5–5mg of protein and antibodies to V5, PCNA (Abcam,
Cambridge, MA), RAD9 (Abcam), or TopoIIa
(TopoGEN, Port Orange, FL), samples were incubated
overnight at 4C, then 25ml of A/G (1:1) agarose beads
(Invitrogen) were added and incubated for 1h at 4C,
centrifuged at 300g for 2min at 4C. Supernatants
were removed and beads were washed four times with
M-PER buﬀer (Thermoscientiﬁc). Beads were centrifuged
at 300g for 2min at 4C, boiled for 10min, and
centrifuged at 300g for 2min at 4C. The supernatants
were transferred to new tubes, samples were boiled for
10min, separated by SDS–PAGE, and analyzed by
western blotting.
Relaxation of positive supercoiled DNA
Positively supercoiled DNA was prepared as described (9).
Positive supercoil relaxation reactions were performed in a
total volume of 20ml in 10mM Tris–HCl, pH 7.9, 175mM
KCl, 0.1mM EDTA, 5mM MgCl2, 2.5% glycerol,
0.5mM ATP (USB Co., Cleveland, OH), 2U TopoIIa,
180ng Metnase (when noted) and 0.3mg DNA. Aliquots
were removed at indicated times and reactions were
stopped with 4ml of 0.77% SDS, 77mM EDTA.
Products were separated on 1% agarose gels and densi-
tometry was performed using Image J software.
Background values were subtracted from signals, resulting
values were normalized to signals at initial time points,
and plotted as function of time in two independent
experiments.
RESULTS
Metnase promotes cell proliferation
Metnase is expressed in a wide variety of human tissues
(17) and in all human cell lines tested, except those trans-
formed by T-antigen such as HEK-293T cells (unpub-
lished results). Overexpression of Metnase in HEK-293T
increases cell proliferation (19). HEK-293 cells express
Nucleic Acids Research, 2010,Vol.38, No. 17 5683Metnase, but not T-antigen, and stable shRNA
knockdown of Metnase in HEK-293 cells signiﬁcantly
reduced cell proliferation rate compared to control cells
(Figure 1A). We have shown previously and conﬁrmed in
this study that Metnase overexpression in HEK-293T in-
creases cell proliferation (Figure 1B). Moreover, cells
stably transfected with Metnase shRNA vectors either
cease to proliferate after 2–3 months or revert to
normal. These results indicate that Metnase promotes pro-
liferation of human cells, and suggest that Metnase is very
important for growth of human cells that do not express
T antigen.
Metnase promotes cell survival and DNA replication after
replication stress
The eﬀect of Metnase on cell proliferation, coupled with
its DNA repair properties and functional interaction with
TopoIIa (17,19), suggested that Metnase may have a role
in replication and/or rescuing cells from replication stress
at sites of spontaneous DNA damage. We therefore tested
whether Metnase regulates sensitivity to replication stress
induced by HU, CPT and UV-B (Figure 2A). Metnase
knockdown sensitized HT1080 cells to 1mM HU by
more than 1000-fold (P=0.01), and to 0.2–0.5mM CPT
by nearly 10-fold (P0.011) (all statistical analyses in this
study were performed by using t-tests). Metnase
knockdown sensitized HEK-293 cells to a UV-B dose of
11.2J/m
2 by nearly 20-fold (P=0.007). When cultured in
a low concentration of HU (0.1mM), HEK-293 cells
proliferated at a slow rate, but Metnase knockdown cells
showed almost no proliferative capacity; this eﬀect specif-
ically reﬂects the Metnase defect since Metnase
overexpression in HEK-293T signiﬁcantly enhanced pro-
liferation under these conditions (Figure 2B). The hyper-
sensitivity of Metnase knockdown cells to replication
stress reﬂects, at least in part, enhanced cell death via
apoptosis, as shown by the nearly 30-fold increase in the
apoptosis marker annexin V, and >6-fold increase in
inviable cells (unable to exclude propidium iodide)
(both P<0.005). The marked sensitivity of Metnase
knockdown cells to replication stress contrasts with their
mild sensitivity to ionizing radiation (17).
To investigate the mechanism by which Metnase
promotes cell proliferation and resistance to replication
stress, we tested whether Metnase expression level
inﬂuenced DNA replication by measuring BrdU incorpor-
ation and cell cycle distributions by ﬂow cytometry, in
unstressed cells and after release from replication stress.
In log phase (untreated) HEK-293 cells, Metnase
knockdown had no eﬀect on BrdU incorporation during
a 30min incubation (Figure 3A). However, when
HEK-293 Metnase knockdown cells were pretreated
with 5mM HU for 3h and then released into BrdU
medium, BrdU incorporation was signiﬁcantly reduced
(2-fold, Figure 3B). The opposite eﬀect was seen with
Metnase overexpression in HEK-293T cells treated with
HU for 18h as BrdU incorporation was signiﬁcantly
increased (Figure 3C). Although neither over- nor
underexpression of Metnase signiﬁcantly aﬀected cell
cycle distributions of unstressed cells (Supplementary
Figure S1A), when treated with 5mM HU for 18h and
released, HEK-293T cells overexpressing Metnase entered
S-phase more rapidly than control cells (seen 1h after
release from HU), and entered G2 phase more rapidly
(seen 7h after release from HU) (Supplementary Figure
S1B). Somewhat stronger eﬀects were seen when Metnase
was overexpressed in HEK-293 cells (Supplementary
Figure S1C); this may reﬂect the fact that HEK-293T
cells show robust proliferation even though they do not
express Metnase. When HEK-293 Metnase knockdown
cells were treated with 5mM HU for 18h and released,
the opposite eﬀect was seen. In two independent
knockdown cell lines, there were marked accumulations
of S phase cells 10 and 18h after release from HU
(Supplementary Figure S1D), indicating that Metnase
knockdown prolongs S phase after replication stress.
These results support the idea that Metnase promotes
DNA replication in cells recovering from replication
stress.
Figure 1. Metnase promotes cell proliferation. (A) Cell growth was monitored in HEK-293 cells transfected with shGFP (control) or shMetnase
vectors. (B) Cell growth was monitored in HEK-293-T cells, which do not normally express Metnase, transfected with the pCAPP-Metnase expres-
sion vector or empty pCAPP. Plotted are averages (±SD) of two to three determinations per time-point. *P<0.05, **P<0.01. Metnase expression is
shown in representative western blots with b-actin loading control (insets). Cell growth was measured by harvesting cells at indicated times and
counting cells with a Coulter counter.
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To gain a better understanding of the role of Metnase in
replication and the replication stress response, we
analyzed replication fork restart, new origin ﬁring, and
replication speed by using DNA ﬁber analysis. Log
phase HEK-293 cells stably transfected with vectors ex-
pressing shRNA targeting Metnase, or GFP as control,
were labeled with IdU for 10min, then incubated with
or without 5mM HU for 1h, brieﬂy washed with thymi-
dine and then incubated with CldU for 20min. Cells were
lysed on glass slides and DNA ﬁbers were stretched by
gravity, ﬁxed, IdU was stained red and CldU was
stained green, and DNA ﬁbers were quantiﬁed using
confocal-microscopy (Figure 4A and B). In untreated
control cells, 90% of ﬁbers showed adjacent red–green
signals indicative of continuing forks. Typically, we did
not observe gaps between red and green signals on indi-
vidual ﬁbers in controls that were not treated with HU,
perhaps because replication is slowed by media changes,
which included a thymidine wash. Approximately 10% of
ﬁbers had only green signals indicating forks that initiated
after IdU was removed (‘new forks’). When control cells
were treated with HU, continuing forks (those that stalled
and restarted) were moderately reduced to 65%
(P=0.0014), new forks that initiated after HU treatment
showed a slight but not statistically signiﬁcant increase to
20%, and 15% of forks stopped and failed to restart.
The pattern observed with untreated Metnase knockdown
cells was similar to untreated wild-type cells, with predom-
inantly continuing forks and a small percentage of new
forks. Strikingly, when Metnase knockdown cells were
treated with HU, the percentage of stopped forks greatly
increased (to 90%) and there was a corresponding large
decrease in the percentage of continuing forks (both
P0.0008). New forks were extremely rare in HU
treated Metnase knockdown cells, however, new forks
are also rare in untreated cells, and the decrease with
HU treatment was not statistically signiﬁcant (P=0.3).
These results provide direct evidence that Metnase plays
Figure 2. Metnase promotes cell survival after DNA replication stress. (A) Average percent cell survival (± SD) after HU, CPT or UV-B treatments
measured as relative plating eﬃciency for HT1080 or HEK-293 cells stably transfected with control or shRNA-Metnase vectors. Data are from two
to three independent experiments per condition; *P=0.0127, **P0.01. (B) Average growth rates (±SD) of control HEK-293 and sh-Metnase
knockdown cells, and control HEK-293T or Metnase overexpression cells in medium containing 0.1mM HU; data are from two to three independent
experiments per cell line. (C) HEK-293 control or Metnase knockdown cells were treated with 5mM HU for 6h and the percentages of cells
expressing annexin V or incorporating propidium iodide were determined by ﬂow cytometry. Values are averages (±SD) from three independent
experiments.
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further suggest that Metnase may regulate new origin
ﬁring when cells experience replication stress.
To determine whether Metnase regulates the speed of
replication, we measured average ﬁber lengths. As
expected, red ﬁbers were shorter than green since cells
were treated with IdU (red) for 10min and CldU (green)
for 20min. Fibers were longer in unstressed cells than after
HU treatment (Figure 4C). However, Metnase had no
eﬀect on ﬁber lengths in either HU treated or untreated
cultures. We conclude that Metnase regulates the eﬃ-
ciency of replication fork restart, and possibly initiation
after replication stress, but it has no eﬀect on the speed of
ongoing forks.
Figure 4. Metnase promotes replication fork restart. (A) IdU and CldU labeling scheme is shown above representative confocal microscope images
of DNA ﬁbers, with IdU stained red and CldU stained green. (B) Quantiﬁcation of ﬁber types. At least 150 ﬁbers were scored per treatment, per cell
line for each of three experiments; **P0.0014. (C) Fiber lengths were measured by using LSM 510 Image Browser software. Plotted are averages
(±SD) of triplicate experiments in which 150–500 ﬁbers were scored per treatment, per experiment. nd, none detected.
Figure 3. Metnase promotes DNA replication after release from replication stress. (A) Log phase HEK-293 cells expressing normal or low levels of
Metnase were incubated with 10mM BrdU for 30min and average percentages (±SD) of BrdU
+ cells are shown for two determinations per strain.
(B) HEK-293 control and Metnase knockdown cells were treated with 5mM HU for 3h and released into medium with 10mM BrdU. Average fold
increases (±SD) in the percentage of BrdU
+cells relative to untreated cells (no HU, no BrdU) are plotted for three independent experiments per cell
line. *P=0.042, **P=0.0047. (C) BrdU incorporation after HU release from HEK-293T control and Metnase overexpression cells as in panel B,
except cells were treated with HU for 18h; *P0.03.
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replication stress
Replication stress causes fork collapse to DSEs marked by
phosphorylation of histone H2AX to g-H2AX.
Elimination of the g-H2AX signal over time reﬂects
DSE/fork repair. Metnase and classical NHEJ proteins
promote survival after replication stress and inﬂuence rep-
lication fork restart (21,24–26) (this study), and Metnase
promotes NHEJ and interacts with the key NHEJ protein
DNA LigIV (17,18). We therefore tested whether Metnase
inﬂuences resolution of HU-induced g-H2AX by treating
cells with 10mM HU for 18h, then releasing into normal
growth medium and examining g-H2AX by immunoﬂuor-
escence microscopy. Because HEK-293 and HEK-293T
cells used in these experiments adhere poorly, cells were
cytospun prior to ﬁxation and immunocytochemical
staining. For this reason, individual g-H2AX foci are
not always detectable. Instead g-H2AX signals typically
appear as diﬀuse nuclear staining and cells were scored as
either g-H2AX positive or negative (representative images
are shown in Figure 5A). Consistent with the enhanced
sensitivity of Metnase knockdown cells to HU, g-H2AX
persisted longer in the knockdown cells, with signiﬁcant
diﬀerences from controls at both 6 and 24h after release
from HU (Figure 5B, P<0.0001). Similarly,
overexpression of Metnase in HEK-293T cells accelerated
the resolution of g-H2AX signals (Figure 5C, P0.0055).
Note that in all four cell lines, similar percentages of cells
were g-H2AX positive at the end of the 18h HU treat-
ment. These results indicate that Metnase promotes reso-
lution of g-H2AX after cells are released from replication
stress, but Metnase does not prevent fork collapse to
DSEs over the course of this relatively long HU treatment.
Metnase is not required for replication stress-induced
RAD51 focus formation
HR is thought to play a major role in resolving stalled and
collapsed replication forks. We showed previously that
Metnase does not aﬀect HR repair of chromosomal
DSBs induced by I-SceI nuclease (17). To determine
whether Metnase inﬂuences fork restart/repair by aﬀecting
RAD51 ﬁlament formation we examined RAD51 foci in
HEK-293 cells stably transfected with control (shGFP) or
Metnase knockdown (shMet) vectors, and treated with
10mM HU for 4h or mock treated (Supplementary
Figure S2). As expected, control cells showed increased
RAD51 foci after HU, reﬂected as statistically signiﬁcant
(3–5-fold) increases in the percentage of cells with at least
one RAD51 focus, or >5 foci. Interestingly, two inde-
pendent Metnase knockdown cell lines showed high per-
centages of foci-positive cells (and cells with >5 foci) in the
absence of HU, but foci were not further increased by HU
treatment. Although the percentage of RAD51
foci-positive cells increased with HU in control cells, and
was high in HU-treated and untreated Metnase
knockdown cells, the average number of RAD51 foci
Figure 5. Metnase promotes resolution of replication stress-induced g-H2AX. (A) Representative confocal microscope images of HEK-293 and
HEK-293T cells over- or under-expressing Metnase were treated with 10mM HU for 18h and released into growth medium for 24h. Aliquots of
cells were removed at indicated times, cytospun, stained with DAPI (blue) and antibodies to gH2AX (green) and imaged by confocal microscopy.
(B, C) Percentage of g-H2AX positive cells among total DAPI stained cells. An average of >190 cells were counted per slide, 10 slides per
experiment. Values are averages (±SD); **P0.0055.
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treatment or Metnase expression level (Supplementary
Figure S2C). These results indicate that Metnase is not
required for RAD51 focus formation after replication
stress, that Metnase suppresses RAD51 focus formation
in unstressed cells, and that cells produce a limited number
of RAD51 foci when experiencing replication stress from
endogenous DNA damage, HU, or Metnase knockdown
(see ‘Discussion’ section).
Metnase co-immunoprecipitates with PCNA and RAD9
Because Metnase is involved in the replication stress
response, we explored its interactions with proteins at
the replication fork. PCNA is a key scaﬀold protein that
mediates binding of numerous proteins in the replisome
and promotes replication processivity (7). Metnase
co-immunoprecipitated with PCNA, and vice versa, in un-
stressed cells and after treatment with HU (Figure 6A).
PCNA-interacting proteins share a conserved binding
motif, the PIP box. Metnase has a highly conserved PIP
box (Supplementary Table S1) suggesting that it directly
interacts with PCNA. Interestingly, Metnase also
co-immunoprecipitated with RAD9, a member of the
9-1-1 complex that is structurally and functionally
related to PCNA, and that is recruited to stalled and/or
collapsed replication forks (Figure 6B). Although this
interaction appeared stronger when RAD9 was
immunoprecipitated from HU treated cells, a similar en-
hancement was not seen with HU treatment when
Metnase was immunoprecipitated. Metnase did not
co-immunoprecipitate with the 32kDa subunit of RPA
(Figure 6C), indicating that Metnase is present within
the replisome, but is not closely associated with ssDNA
at stalled forks. These results indicate that Metnase is
closely associated with replication stress factors that
control TLS, fork processing via HR mechanisms, and
checkpoint signaling.
Metnase interacts with TopoIIa and promotes TopoIIa-
dependent relaxation of positively supercoiled plasmid
DNA
Metnase interacts with TopoIIa and promotes
TopoIIa-dependent chromosome decatenation (19).
TopoIIa is present in the replisome (11) and has been
implicated in DNA replication through relaxation of
positive supercoils that accumulate ahead of replication
forks (9). We found that Metnase signiﬁcantly enhanced
TopoIIa-dependent relaxation of positive supercoils
during a 5min time course, but Metnase was not
required to achieve full relaxation within an hour
(Figure 7A and B). To gain insight into whether
Metnase functions in the replication stress response
through its interaction with TopoIIa, we tested whether
the interaction between Metnase and TopoIIa was
aﬀected by replication stress. HEK-293 cells were treated
with 5mM HU for 3h, and cell extracts were prepared
and analyzed by co-immunoprecipitation of Metnase
and TopoIIa. As shown in Figure 7C, Metnase and
TopoIIa show a robust interaction regardless of which
protein was immunoprecipitated, but this interaction
was not aﬀected by HU treatment. These results suggest
that Metnase interaction with TopoIIa may promote
TopoIIa processing of DNA structures in front of repli-
cation forks.
DISCUSSION
Although Metnase appeared very late in evolution, in an-
thropoid primates (27), it inﬂuences several important
aspects of DNA metabolism including NHEJ, DNA inte-
gration, chromosome translocation and chromosome
decatenation (17–20,28). Through interaction with
TopoIIa, it regulates cellular resistance to common
chemotherapeutics (22,29). The present study establishes
another important role for Metnase in the replication
stress response. Given how late Metnase appeared in evo-
lution, it is not surprising that it does not inﬂuence repli-
cation fork progression. Instead, Metnase functions
during replication stress since Metnase aﬀected BrdU
Figure 6. Metnase interacts with PCNA and RAD9, but not RPA32.
(A) Reciprocal co-immunoprecipitation of V5-tagged Metnase
and native PCNA from cells treated with 5mM HU for 18h, tested
immediately or 30min after release from HU, or untreated.
Input represents 0.5% of immunoprecipitation. Results are repre-
sentative of at least three independent experiments. (B and C)
Co-immunoprecipitation of V5-tagged Metnase with native RAD9
and native RPA as in panel A, except HU treated cells were only
tested immediately after treatment.
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DNA ﬁber analysis only when cells were subjected to rep-
lication stress (Figures 3 and 4, Supplementary Figure S1).
Metnase knockdown conferred a marked defect in fork
restart during a 20min period after a brief (1h) HU treat-
ment (Figure 4). This result indicates that Metnase plays a
key role in restarting stalled forks, because the brief HU
treatment causes mainly fork stalling. Also, when forks
collapse, restart is largely dependent on HR, an inherently
slow process that involves RAD51 replacement of RPA on
ssDNA, and strand invasion of sister chromatids by
RAD51 ﬁlaments (5). When cells were subjected to
longer periods of replication stress, Metnase promoted
resolution of g-H2AX (Figure 5), which marks collapsed
forks. This indicates that Metnase also promotes repair of
collapsed forks. Another late-evolving protein that func-
tions in replication fork restart is PARP-1. PARP-1 is not
found in yeast, but is present in higher eukaryotes.
PARP-1 recruits the ancient DNA repair endonuclease
MRE11 to stalled forks, which is proposed to process
structures at stalled forks, leading to RPA recruitment
and eventual restart via HR (30).
Metnase might promote replication fork restart/repair
in a variety of ways, as illustrated in Figure 8. Metnase
promotes NHEJ (17) and other factors involved in NHEJ
are known to promote cell survival after replication stress
(16,25). NHEJ factors might promote rejoining of DSEs
at collapsed forks, but it seems that this type of repair
would be highly inaccurate (and genome destabilizing)
since each collapsed fork produces only a single broken
end. It is possible that NHEJ factors promote fork restart
indirectly through interactions with HR factors (23).
When replication forks stall, the initial cellular response
is to stabilize the replisome to prevent fork collapse.
Metnase does not appear to play a role in fork stabiliza-
tion over an extended period of replication stress, because
altering Metnase levels had no eﬀect on the percentage of
cells with collapsed forks (g-H2AX positive) after an 18h
HU treatment (Figure 5). Although it is clear that
Metnase promotes resolution of g-H2AX, further studies
are required to determine whether this reﬂects enhanced
repair of collapsed forks via NHEJ, HR, or other mech-
anisms such as fork rescue from adjacent replicons. It is
also possible that the Metnase nuclease plays a role in fork
processing, as with Mus81 (31).
Metnase is not required for HR stimulated by I-SceI
nuclease-induced DSBs (17) nor for RAD51 focus forma-
tion in response to replication stress (Supplementary
Figure S2). Thus, Metnase does not aﬀect RAD51
ﬁlament formation, which involves RAD51 replacement
of RPA on ssDNA; this is consistent with the lack of
interaction between Metnase and RPA (Figure 6C).
Metnase knockdown cells show high frequencies of
RAD51 foci, but foci do not increase upon treatment
with HU. This suggests that Metnase knockdown itself
is a form of replication stress, consistent with the slow
growth phenotype (Figure 1A), and that RAD51 focus
formation is somehow limited, for example, because of
RAD51 availability, or because multiple forks are seques-
tered in a limited number of ‘repair centers’ (32,33). The
repair center concept can also account for the similar
number of RAD51 foci per cell with foci in HU treated
or untreated wild-type and Metnase knockdown cells
(Supplementary Figure S2C).
Metnase could promote fork restart through its inter-
actions with the replisome factors PCNA and RAD9.
Although it is not yet known whether Metnase interacts
directly with these proteins, the fact that the Metnase SET
domain has a conserved PIP box is highly suggestive of
direct interactions with these related proteins. Regardless,
our results clearly place Metnase in the vicinity of stalled
replication forks. The Metnase SET domain encodes a
protein methylase, and Metnase is known to methylate
histone H3 and itself (17,19). Metnase could regulate
PCNA and/or RAD9 function by methylating these
proteins. PCNA regulates TLS through direct interactions
with TLS polymerases (7), thus Metnase may enhance
fork restart after UV by enhancing TLS at UV lesions.
RAD9 has well-established roles in the intra-S check-
point response (5). Metnase could promote fork restart by
inﬂuencing checkpoint activation; it may also aﬀect down-
stream checkpoint-dependent processes such as inhibition
of origin ﬁring. We are currently investigating the eﬀects
of Metnase on checkpoint factors downstream of RAD9,
including Chk1. Metnase is not required for the p53/Chk2
arm of the DNA damage checkpoint response since repli-
cation stress-induced cell death in Metnase knockdown
Figure 7. Metnase interacts with TopoIIa and stimulates relaxation of positive supercoils. (A) Predominantly positively-supercoiled plasmid DNA
samples were treated with TopoIIa (2 U) with or without Metnase (180ng) for indicated times, and topological forms were detected on ethidium
bromide stained agarose gels. (B) Gel images were scanned and the percentage of positively-supercoiled DNA remaining at each time point was
quantitated. Values are averages (±SD) of two determinations per condition, normalized to 100% at t=0; **P=0.007. (C)
Co-immunoprecipitation of V5-tagged Metnase and native TopoIIa; data presented as in Figure 6B.
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Metnase may have a more general role in fork restart
through chromatin modiﬁcation in the vicinity of stalled
and collapsed forks. It is noteworthy that Metnase methy-
lates histone H3 lysines 4 and 36, which are speciﬁcally
associated with ‘open’ chromatin (17). Thus, Metnase
could promote fork restart by enhancing access of repair
factors to stalled and collapsed forks.
Finally, Metnase could inﬂuence fork restart through its
direct interaction with TopoIIa, another factor within the
mammalian replisome (11). TopoIIa is proposed to relax
positive supercoils that form ahead of replication forks
(9). When replication forks stall, the MCM helicase
complex can continue to unwind duplex DNA, uncoupled
from the replicative polymerases, producing excess
ssDNA that is bound by RPA and triggering the intra-S
checkpoint (5,34). Continued DNA unwinding by MCM
will also increase positive supercoiling that may drive
unusual DNA structures at stalled forks (34). By
enhancing TopoIIa-dependent relaxation of positive
supercoils, Metnase could promote a favorable topologic-
al state that results in timely fork restart, particularly
when unusual structures form, such as ‘chicken feet’,
since the resolution of such structures is probably depend-
ent on the topology of the stalled fork. Local topology
could also inﬂuence restart of collapsed forks since
HR-mediated invasion of broken ends into sister chroma-
tids requires unwinding of the sister duplex. Note that the
models described above are not mutually exclusive:
Metnase may have diﬀerent roles depending on the
speciﬁc structures at stalled or collapsed replication forks.
Prior studies have established that Metnase is highly
expressed in actively proliferating tissues (17). We have
recently shown that Metnase is frequently overexpressed
in leukemia and breast cancer cell lines, and importantly,
down-regulating Metnase greatly enhances tumor cell sen-
sitivity to common chemotherapeutics including epidido-
phylotoxins and anthracyclines (22,29). The current study
establishes Metnase as a critical factor in the replication
stress response. Metnase is therefore an excellent target for
therapeutic strategies that block DNA synthesis, or that
exploit defects of tumor cells in replication fork restart
(35,36), and it may thus prove to be an important target
in the treatment of a wide variety of tumor types.
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